Skip to main content
. 2002 Dec;46(12):3861–3868. doi: 10.1128/AAC.46.12.3861-3868.2002

TABLE 3.

Summary of enrolled sample profile and results of the assay

Patient profile Sequence resultg as determined by:
No. Treatment (durationf) Viral load (log) CD4 (mm3) Direct sequence
MS-PCR
M41 D67 K70 L210 T215 K219 M41 K70
1 ZDV + ddC (2.3Y) 4.6 223 M N R L I Q M R
2 Naive 4.1 404 M D K L T K M K
3 Naive 4.6 565 M D K L T K M K
4 Naive 5.9 165 M D K L T K M K
5 Past ZDVa 5.2 90 M D K M T K M K
6 Naive 5.9 0 M D K L T K M K
7 Naive 4.2 371 M D K L T K M K
8 Naive 5.6 284 M D K L T K M K
9 ZDV + 3TC + NVP (1M) 2.6 127 M D K L T K M/L Kh
10 Naive 4.8 306 M D K L T K M K
11 Naive 5.5 226 M D K L T K M K
12 Naive 6.0 61 M D K L T K M K
13 ZDV + ddI (2Y) 5.3 329 M D K L T K M K
14 ZDV + 3TC + NVP (2M) 2.6 106 M D K L T K M K
15 Naive 3.9 441 M D K L T K M K
16 Naive 5.2 869 M D K L T K M K
17 Naive 5.5 0 M D K L T K M K
18 Past ZDVb 4.9 607 M D K L T K M K
19 Naive 6.0 20 M D K L T K M K
20 Naive 5.5 133 M D K L T K M K
21 Past ZDV + ddIc 4.2 389 M D K L T K M K
22 Naive 4.5 416 M D K L T K M K
23 ZDV + ddC (6M) 5.1 489 M D R L Y Q M/L Rh
24 ZDV + ddI/ddC (7M) 5.3 321 M D K L T K M K
25 Naive 4.6 556 M D K L T K M K
26 Naive 3.4 531 M D K L T K M K
27 Naive 4.2 224 M D K L T K M K
28 Naive 4.1 297 M D K L T K M K
29 Naive 5.8 41 M D K L T K M K
30 Naive 6.2 29 M D K L T K M K
31 Naive 4.5 415 M D K L T K M K
32 Naive 5.4 177 M D K L T K M K
33 Past ZDVd 4.8 45 M D K L T K M K
34 Naive 5.2 69 M D K L T K M K
35 Naive 5.5 44 M D K L T K M K
36 ZDV + 3TC/ddI (2Y) 3.6 271 M D K L T K M K
37 ZDV/3TC + d4T (2Y) 5.5 117 M/L N R L F Q M/L R
38 ZDV + 3TC/+ddI + d4T (4Y) 5.6 8 M N R W F K M R
39 ZDV + ddI/ddC (3.5Y) 3.9 6 L N K W Y N L K
40 ZDV + ddI/ddC/3TC (3Y) 5.1 13 M D K L I K M K
41 ZDV + 3TC (3Y) 3.9 373 M D K L T K M K
42 ZDV + ddI/3TC (2.5Y) 4.6 49 L N K W Y K M/L Kh
43 ZDV + 3TC (10M) 5.5 9 M D K L T K M K
44 ZDV + 3TC (0.5M) 4.7 55 M D K L T K M K
45 ZDV + ddC/3TC (2.7Y) 4.6 76 L N R L F Q L R
46 Past ZDV + ddC/3TCc 4.7 1 M D K L T K M K
47 ZDV/+ ddC (4.5M) 5.2 0 M N R L F K M/L Rh
48 Naive 3.1 509 M D K L T K M K
49 Naive 5.8 78 M D K L T K M K
50 ZDV + ddC (1.5M) 2.6 NDi M D K L T K M K
51 ZDV + ddI/ddC (2.5Y) 4.6 27 L N K W Y K L K
a

History of 1 months of ZDV monotherapy 2 years ago.

b

History of 2 months of ZDV monotherapy 2 years ago.

c

History of 4 months of ZDV + ddI dual therapy 2 years ago.

d

History of 1 month of ZDV monotherapy 2 years ago.

e

History of 1.4 years of ZDV + ddI/3TC dual therapy 1 year ago.

f

M, months; Y, years.

g

Mutants are indicated in boldface.

h

This case had discordant results between direct sequencing and MS-PCR

i

ND, no data.